VBLT Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 okt 2023 @ 22:00):

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States...

Stats
Dagens volum	5.38M
Gjennomsnittsvolum	787 717
Markedsverdi	12.11M
EPS	$-0.0111 ( Q2 \| 2023-08-14 )
Neste inntjeningsdato	( $0 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.867 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0180 (11.61%)

AADI -6.18%

ABCL 2.38%

ABCM 0.04%

ABEO -3.32%

ABIO -1.68%

ABOS 5.14%

ABSI 4.08%

ABUS -0.82%

ABVX -1.88%

ACAD 0.00%

ACER -17.95%

ACET -8.84%

ACGN 1.29%

ACHL -2.48%

ACHV 3.89%

ACIU -1.00%

ACLX 0.09%

ACRV -5.61%

ACST -4.89%

ACXP 3.92%

ADAG 6.07%

ADAP -2.77%

ADGI 0.87%

ADIL -1.70%

ADMA -1.77%

ADPT 0.74%

ADTX -2.78%

ADVM 1.45%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -2.82%

AGIO -1.90%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.19%

AKRO -2.45%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.80%

ALEC 0.00%

ALGS 1.32%

ALKS 1.86%

ALLK -11.49%

ALLO -3.96%

ALLR -3.34%

ALNA 3.16%

ALNY 2.27%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -13.92%

ALVR -0.69%

ALXN 0.00%

ALXO -13.55%

ALZN 4.02%

AMRN -2.50%

AMTI -3.13%

ANAB 1.64%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 2.40%

ANPC -3.15%

APGE 0.75%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 1.06%

APLT -0.45%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 2.04%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.52%

ARDS -12.13%

ARDX 0.90%

ARGX -0.49%

ARNA 0.00%

ARPO -0.90%

ARQT -2.50%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.65%

ARWR -1.64%

ASLN -3.43%

ASMB -4.22%

ASND -2.14%

ATAI -3.33%

ATHA 6.86%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 4.83%

ATRA -3.60%

ATXI 2.70%

ATXS -0.22%

AUPH -0.99%

AURA 4.55%

AUTL -3.02%

AVBP -3.26%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE 0.34%

AVTX -3.74%

AVXL -4.93%

AXLA 0.00%

AXSM -1.29%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.16%

BCAB -3.01%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.93%

BCTX 8.16%

BCTXW 13.02%

BCYC 1.22%

BDRX -4.09%

BDTX 0.23%

BEAM 2.56%

BFRA -2.91%

BGNE -2.02%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.47%

BLTE -1.03%

BLU 0.03%

BLUE -2.28%

BMEA -13.82%

BMRN 0.51%

BNOX 6.15%

BNTC -1.69%

BNTX -1.75%

BOLD -7.90%

BOLT -0.05%

BPMC -1.44%

BPTH -1.90%

BPTS -13.47%

BRNS -0.37%

BRTX -6.13%

BTAI 12.71%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 1.73%

CADL 0.62%

CALA 0.00%

CALC -11.42%

CALT -1.59%

CAPR -1.08%

CARA -3.29%

CARM 6.96%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.76%

CCXI 0.00%

CDAK 0.00%

CDIO -5.08%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.79%

CDXS 9.31%

CELC -3.12%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.52%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM -0.03%

CGEN -3.31%

CGON -1.53%

CGTX -4.35%

CHMA -6.00%

CHRS 4.11%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.58%

CLGN -0.20%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 6.67%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.65%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.54%

CNCE 0.00%

CNSP -36.24%

CNST 0.00%

CNTA 0.00%

CNTB -0.75%

CNTX -4.79%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.53%

COYA -0.65%

CPRX -1.72%

CRBP -0.43%

CRBU -6.26%

CRDF 1.77%

CRGX 0.10%

CRIS -1.59%

CRNX -5.91%

CRSP -0.07%

CRTX 2.63%

CRVO -2.33%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.29%

CTNM 1.98%

CTXR -1.31%

CUE -1.73%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.53%

CYTO 0.00%

DARE 3.54%

DAWN -0.75%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.32%

DNLI -1.61%

DNTH -4.46%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -2.73%

EDSA 4.09%

EFTR 5.36%

EFTRW -53.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.65%

ELEV -0.41%

ELOX 10.77%

ELTX -5.15%

ELVN -1.82%

ELYM 4.60%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA 0.08%

ENTO -4.97%

ENTX -0.53%

ENVB 8.03%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.00%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.82%

ETON 3.35%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.21%

EXAI -0.19%

EXEL 0.47%

EYEG -0.69%

EYEN 0.68%

EYPT 1.69%

FATE -11.42%

FBIO 0.86%

FBIOP 0.87%

FBLG -7.30%

FBRX -0.02%

FDMT -4.70%

FENC -2.26%

FGEN -10.21%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.37%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.16%

FULC 1.67%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.43%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.43%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 5.01%

GLTO -3.31%

GLUE -3.43%

GLYC -11.78%

GMAB -0.35%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.42%

GNPX -2.46%

GNTA 3.94%

GOSS -10.88%

GOVX -2.73%

GOVXW 10.89%

GPCR -6.23%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.01%

GRTX -1.66%

GTHX 1.36%

GUTS 2.77%

GXGXW 41.67%

GYRE -4.54%

HALO -1.67%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -1.34%

HOOK 0.89%

HOTH -1.10%

HOWL 1.93%

HRMY 5.00%

HRTX 9.02%

HSTO 0.00%

HUMA 1.52%

HUMAW -6.26%

IBRX -5.43%

ICCC -4.42%

ICPT 0.21%

ICU 15.41%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.10%

IFRX -2.78%

IGMS -1.02%

IKNA -0.30%

IKT -9.93%

IMAB 0.00%

IMCR -3.36%

IMGN 0.02%

IMGO 0.00%

IMMP 4.37%

IMMX -6.93%

IMNM 4.25%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.00%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -3.26%

INAB -1.68%

INBX -2.52%

INCY -2.39%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 3.22%

INMB 4.90%

INO 1.82%

INSM -0.98%

INTS -1.96%

INVA 0.29%

INZY 2.29%

IOBT -10.24%

IONS 1.50%

IOVA -2.40%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.48%

ISEE 0.38%

ITOS 1.23%

ITRM 2.33%

IVA 6.96%

IVVD -0.41%

JAGX 1.57%

JANX -4.56%

JAZZ -0.83%

JNCE 0.00%

JSPR -2.16%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -4.16%

KDNY 0.22%

KMPH -0.34%

KNSA -1.85%

KNTE -0.38%

KOD -7.31%

KPRX -3.60%

KPTI -8.93%

KRBP -10.00%

KRON 1.68%

KROS -0.41%

KRRO -2.30%

KRTX 0.03%

KRYS 0.27%

KTRA 11.86%

KTTA -0.65%

KTTAW 0.92%

KURA 0.54%

KYMR -2.79%

KYTX -3.23%

KZIA 4.41%

KZR -0.12%

LABP 0.57%

LBPH -0.25%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.96%

LENZ -1.92%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -9.31%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA 0.41%

LRMR 0.78%

LSTA -1.68%

LTRN 6.48%

LUMO 1.79%

LVTX -4.12%

LXEO -8.77%

LXRX -2.06%

LYEL -34.83%

LYRA 1.94%

MACK 0.10%

MBIO -11.56%

MBRX -1.43%

MCRB 2.61%

MDGL -2.34%

MDNA -13.16%

MDWD 3.56%

MDXG -2.06%

MEIP 0.00%

MESO -1.63%

MGNX -4.20%

MGTA -7.74%

MGTX -0.95%

MGX 2.41%

MIRM 0.45%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -7.68%

MLECW 2.31%

MLND -5.36%

MLTX 0.10%

MLYS -5.96%

MNKD -0.76%

MNMD 4.38%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.45%

MORF -3.46%

MREO -2.00%

MRKR -0.43%

MRNA -9.55%

MRNS -5.51%

MRSN -2.62%

MRTX -0.17%

MRUS -0.58%

MRVI -0.58%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.33%

MYMD 1.08%

NAMS -0.66%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.70%

NKGN 9.91%

NKGNW -18.03%

NKTR 4.67%

NKTX -4.00%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.09%

NMTR -42.97%

NOVN -24.84%

NRBO 16.39%

NRIX -0.39%

NRSN -4.82%

NRSNW 0.00%

NRXP -9.17%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.21%

NTRBW -31.07%

NUVL -0.98%

NVAX -7.64%

NVCT -7.75%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 3.17%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 8.90%

OCS -1.00%

OCUL 1.14%

OCUP 1.32%

ODT -4.27%

OKYO 2.15%

OLMA -4.77%

OMER -2.31%

OMGA 0.63%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -1.19%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.53%

OVID 0.01%

OYST 0.00%

PALI -0.22%

PASG 2.63%

PBLA -7.50%

PBM -2.18%

PBYI 2.88%

PCSA -1.93%

PCVX 0.00%

PDSB -6.65%

PEPG 1.19%

PGEN -5.99%

PHAR 2.19%

PHAS 0.00%

PHAT -0.48%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.02%

PLUR 7.39%

PMN -5.55%

PMVP -2.08%

PNT 0.16%

PPBT -6.43%

PRAX 7.11%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.18%

PRTA -2.72%

PRTC 0.62%

PRTG 1.00%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.52%

PTCT -0.63%

PTE -0.82%

PTGX -0.95%

PTIXW -48.41%

PULM 1.53%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -7.22%

QNCX 5.70%

QNRX -0.15%

QSI -35.63%

QSIAW -3.13%

QTTB 1.83%

QURE -0.78%

RAIN -1.63%

RANI 4.81%

RAPT -1.30%

RARE 1.91%

RCKT -9.64%

REGN -0.24%

RENB -2.78%

REPL -1.47%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.96%

RGNX -6.58%

RIGL -6.25%

RLAY -4.45%

RLMD 0.00%

RLYB -4.36%

RNA 1.95%

RNAC -4.70%

RNAZ 0.00%

RNXT 1.79%

ROIV -1.71%

ROIVW 4.56%

RPHM -1.39%

RPRX -0.59%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.54%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.70%

RYTM -5.92%

RYZB 0.02%

RZLT 3.50%

SABS -1.37%

SABSW -11.81%

SAGE 0.64%

SANA -2.58%

SAVA -1.48%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -3.51%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.39%

SGMT -5.43%

SGTX -2.56%

SIOX 22.63%

SLDB -4.14%

SLGL 5.23%

SLN -6.37%

SLNO 0.77%

SLRX 1.21%

SLS -2.56%

SMMT -3.00%

SNDX 3.33%

SNGX -0.38%

SNPX -2.55%

SONN -2.13%

SPPI -0.49%

SPRB -1.38%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.17%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -1.34%

STSA 0.00%

STTK 6.61%

SURF -0.93%

SVRA -0.40%

SWTX 0.08%

SYBX 1.29%

SYRS -1.72%

TALS -0.73%

TARA -7.38%

TARS -2.01%

TBPH 0.77%

TCBP 6.94%

TCDA 0.00%

TCON -0.34%

TCRR 0.00%

TCRT -1.75%

TCRX 4.85%

TECH -0.82%

TENX -0.32%

TERN -8.49%

TFFP -7.61%

TGTX -6.96%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.34%

TNXP -6.80%

TNYA -3.68%

TPST 6.45%

TRDA -4.67%

TRVI 3.07%

TRVN 3.11%

TSHA -19.07%

TSVT -3.72%

TTNP -6.05%

TVTX 3.14%

TYRA -6.95%

UBX -2.55%

UNCY -4.44%

URGN 2.67%

UTHR -0.10%

VACC 11.36%

VALN -6.70%

VAXX 94.50%

VBIV 0.93%

VBLT -8.77%

VCEL 0.94%

VCNX 9.03%

VCYT -0.84%

VERA -5.51%

VERU 3.02%

VERV -2.20%

VIGL -1.88%

VINC 2.93%

VIR -0.76%

VIRI -5.72%

VIRX 3.98%

VKTX -1.70%

VLON -13.04%

VNDA -4.07%

VOR -6.05%

VRCA 0.36%

VRDN -3.53%

VRNA -1.60%

VRPX 1.02%

VRTX 0.09%

VSTM 3.91%

VTGN -1.51%

VTVT 0.39%

VTYX -2.55%

VXRT -1.77%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -0.60%

WVE -8.50%

XBIO 1.03%

XBIT 7.50%

XCUR 3.77%

XENE -1.87%

XERS 5.26%

XFOR 5.21%

XLO 4.42%

XLRN 0.00%

XNCR 0.62%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.06%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.07%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Fr Capital Holdings, L.p.	Sell	50 000	Ordinary Shares, par value NIS 0.35 each
2023-12-28	Fr Capital Holdings, L.p.	Sell	21 500	Ordinary Shares, par value NIS 0.35 each
2023-12-29	Fr Capital Holdings, L.p.	Sell	6 000	Ordinary Shares, par value NIS 0.35 each
2023-12-26	Fr Capital Holdings, L.p.	Sell	11 456	Ordinary Shares, par value NIS 0.35 each
2023-12-27	Fr Capital Holdings, L.p.	Sell	20 033	Ordinary Shares, par value NIS 0.35 each

INSIDER POWER
-43.58
Last 32 transactions
Buy: 525 000 \| Sell: 1 196 932

Volum Korrelasjon

Lang: 0.12 (neutral)

Kort: -0.68 (moderate negative)

Signal:(31.998) Neutral

Vascular Biogenics Ltd Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Vascular Biogenics Ltd Korrelasjon - Valuta/Råvare

-0.38
( neutral )

0.16
( neutral )

0.00
( neutral )

0.55
( weak )

Vascular Biogenics Ltd Økonomi

Annual	2022
Omsetning:	$658 000
Bruttogevinst:	$554 000 (84.19 %)
EPS:	$-0.420

FY	2022
Omsetning:	$658 000
Bruttogevinst:	$554 000 (84.19 %)
EPS:	$-0.420

FY	2021
Omsetning:	$768 000
Bruttogevinst:	$403 000 (52.47 %)
EPS:	$-0.685

FY	2020
Omsetning:	$922 000
Bruttogevinst:	$528 000 (57.27 %)
EPS:	$-0.550

Financial Reports:

No articles found.

Vascular Biogenics Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Vascular Biogenics Ltd

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.